Insulin Resistance Intervention After Stroke Trial
What is the purpose of this trial?
The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.
- 40 Years and older
- National Institute of Neurological Disorders and Stroke (NINDS)
Takeda Pharmaceuticals North America, Inc.
- February 2005
- Last Updated:
- August 3, 2011
- Study HIC#:
Clinicaltrials.gov ID: NCT00091949